Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular matrix (ECM) and cell surface adhesion receptors constitute a complex structural and functional network that provides physical support and biochemical signaling cues to cells (Source: Nature Reviews Molecular Cell Biology, "The extracellular matrix at a glance"). This scaffold includes fibrous proteins like collagen and glycoproteins like fibronectin, which serve as ligands for cell surface receptors such as integrins and cadherins (Source: Molecular Biology of the Cell, Alberts et al.). These interactions govern critical biological processes, including cell adhesion, migration, and differentiation. In disease states, such as cancer, the ECM is often remodeled to promote tumor invasion and metastasis, while in fibrotic diseases, excessive ECM deposition leads to organ dysfunction (Source: Journal of Cell Science, "ECM remodeling in health and disease"). Therapeutic interventions often target specific components of this system; for example, monoclonal antibodies like Natalizumab target integrins to treat multiple sclerosis by preventing leukocyte adhesion (Source: FDA Label, Tysabri). Because this entry describes a broad structural context rather than a single protein, it is considered a functional category rather than a discrete molecular target.
Modulation of cell-cell and cell-matrix interactions through the inhibition of specific adhesion receptors or the modification of extracellular matrix components.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix and cell surface adhesion receptors (ECM/CSAR).